Toggle navigation
Home
Search
Services
Blog
Contact
About
A Standard Repository of DNA for Human Gene Mapping
Kouri, Richard Ellis
Genaissance Pharmaceuticals, Inc., New Haven, CT, United States
Search 10 grants from Richard Kouri
Search grants from Genaissance Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Trial to Explore the Benefits of Antimicrobial Self-Sanitizing Surfaces on Bio-Burden Levels and Healthcare-Acquired Infections.
Local calcium release events in skeletal muscle
Live, Attenuated Rotavirus Vaccines
Development of the Olfactory System
Cell Biology and Physiology of Gustatory Transduction
Recently added grants:
Metabolomics Core
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
Allergen T cell epitopes during the management of peanut allergic disease
Development of FRESH (Fast Rescue Employing Self-Helper virus) - a rapid, generalizable method to rescue infectious virus from noninfectious genomic material
Allergen T cell epitopes during the management of peanut allergic disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA040853-02A5
Application #
3506454
Study Section
(SSS)
Project Start
1989-09-22
Project End
1991-08-31
Budget Start
1989-09-22
Budget End
1990-08-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Genaissance Pharmaceuticals, Inc.
Department
Type
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06511
Related projects
NIH 1990
R44 CA
A Standard Repository of DNA for Human Gene Mapping
Kouri, Richard Ellis / Genaissance Pharmaceuticals, Inc.
NIH 1989
R44 CA
A Standard Repository of DNA for Human Gene Mapping
Kouri, Richard Ellis / Genaissance Pharmaceuticals, Inc.
Comments
Be the first to comment on Richard Kouri's grant